Short communication: Persistence of high blood levels of the chemokines CCL2, CCL19, and CCL20 during the course of HIV infection

AIDS Research and Human Retroviruses

Volumn 27, Issue 6, 2011, Pages 655-657

  Fontaine, Julie ^a   Poudrier, Johanne ^a   Roger, Michel ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL;

EID: 79957614654     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0261     Document Type: Article

References (10)

1. Fontaine J, Coutlee F, Tremblay C, Routy JP, Poudrier J, and Roger M: HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. J Infect Dis 2009;199:1007-1018
2. Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, Jerandi G, et al.: Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002;168:4796-4801 (Pubitemid 34441389)
3. Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F, et al.: Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001;98: 2574:2576
4. Macatonia SE, Lau R, Patterson S, Pinching AJ, and Knight SC: Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990;71:38-45 (Pubitemid 20296069)
5. Tacke F and Randolph GJ: Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006;211: 609-618
6. Ansari AW, Bhatnagar N, Dittrich-Breiholz O, Kracht M, Schmidt RE, and Heiken H: Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int Immunol 2006;18:1443-1451 (Pubitemid 44446822)
7. Izadpanah A, Dwinell MB, Eckmann L, Varki NM, and Kagnoff MF: Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: Mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol 2001;280:G710-G719
8. Nagira M, Sato A, Miki S, Imai T, and Yoshie O: Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues Virology 1999;264:422-426
9. Saleh S, Solomon A, Wightman F, Xhilaga M, Cameron PU, and Lewin SR: CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4ρT cells to HIV-1 infection: A novel model of HIV-1 latency. Blood 2007;110: 4161-4164 (Pubitemid 351377777)
10. Damas JK, Landro L, Fevang B, Heggelund L, Tjonnfjord GE, Floisand Y, et al.: Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication. Clin Exp Immunol 2009;157:400-407